The development of therapies for SARS-CoV-2 infection, based on virus biology and
pathology, and of large-and small-scale randomized controlled trials, have brought forward …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination plays a crucial
role as pivotal strategy to curb the coronavirus disease-19 (COVID-19) pandemic. The …

Background Influenza A virus have a distinctive ability to exacerbate SARS-CoV-2 infection
proven by in vitro studies. Furthermore, clinical evidence suggests that co-infection with …

Objective To assess the effects of COVID-19 vaccines in women before or during pregnancy
on SARS-CoV-2 infection-related, pregnancy, offspring and reactogenicity outcomes …

Background As the body of evidence on COVID-19 and post-vaccination outcomes
continues to expand, this analysis sought to evaluate the public health impact of the Pfizer …

This real-world study explores the effect of coronavirus disease 2019 (COVID-19)
inactivated vaccines on the prevention of asymptomatic or mild Delta or Omicron variant …

Several vaccines have been approved for the prevention of COVID-19. However, no head-to-
head trials comparing their clinical efficacy have been performed. This network meta …

Background A suboptimal response to the 2-dose COVID-19 vaccine series in the
immunocompromised population prompted recommendations for a 3rd primary dose. We …

Background On 20th September 2022, the Ugandan Ministry of Health (MOH) declared an
outbreak of haemorrhagic fever caused by the Sudan Ebola virus (SUDV) following …

SARS-CoV-2 is the cause of the COVID-19 pandemic which has claimed more than 6.5
million lives worldwide, devastating the economy and overwhelming healthcare systems …